AVB-114 ( DrugBank: - )
1 disease
| ID | Disease name (Link within this page) | Number of trials |
|---|---|---|
| 96 | Crohn disease | 1 |
96. Crohn disease
Clinical trials : 2,442 / Drugs : 1,278 - (DrugBank : 248) / Drug target genes : 142 - Drug target pathways : 209
| No. | TrialID | Date_ enrollment | Date_ registration | Public_title | Scientific_title | Condition | Intervention | Primary_ sponsor | Secondary_ sponsor | Recruitment_ Status | Inclusion_ agemin | Inclusion_ agemax | Inclusion_ gender | Target_ size | Phase | Countries |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | NCT04847739 (ClinicalTrials.gov) | September 13, 2021 | 1/4/2021 | Seeded Cells on Matrix Plug Treating Crohn's Perianal Fistulas (STOMP-II) | Seeded Cells on Matrix Plug Treating Crohn's Perianal Fistulas (STOMP-II) | Perianal Fistula;Crohn's Disease | Procedure: Seton Placement;Drug: AVB-114 | Avobis Bio, LLC | Alimentiv Inc. | Recruiting | 18 Years | 70 Years | All | 60 | Phase 2 | United States |